ESR1 and breast cancer: In vitro analysis demonstrated that MIR205HG is a functional polymorphic gene whose overexpression increased ERα expression leading to augmented cell proliferation in ERα+ BC cells; however, when BC cells were treated with AI therapy (anastrozol or exemestane), a decrease in both MIR205HG lncRNA and ESR1—the gene encoding ERα—expression was evident.